BREAKING: FDA authorizes Pfizer boosters for 12- to 15-year olds

NEW YORK, NY (ABC) – The Food and Drug Administration on Monday approved Pfizer boosters for 12- to 15-year-olds.

The moves comes as schools reopen after the holiday break.

In a release, the FDA said it has amended the emergency use authorization for the Pfizer vaccine to also shorten the time between the completion of primary vaccination of the Pfizer vaccine and a booster dose to at least five months, instead of six.  It also allows for a third primary series dose for certain immunocompromised children 5 through 11 years of age.
Sponsored Content